View Author
dai: 07296698X
scopus: 7102014576
Eggermont, A.M.M.
(Alexander Eggermont)Supervisor (promotor) of 18 dissertations
patient melanoma cancer tumor study survival treatment metastase oncol trial lymph perfusion factor sentinel group response result resection disease melphalan limb perfusion liver stage month tumour therapy prognostic effect analysis signi table tissue surgery necrosis tumor necrosis factor melanoma patients sarcoma metastatic adjuvant chemotherapy eggermont hepatic phase number procedure interferon breast rectal cancer level colorectal eortc recurrence toxicity activity biopsy value rectal metastasi sentinel node biopsy combination dissection oncology cutaneous melanoma sentinel node outcome vaccine blood center lymph node dissection concentration control thickness follow-up burden rotterdam expression colorectal liver metastases lymph nodes ficant liver metastases
10 Most Recent Publications
|
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)
(Article)
Busse, A. Rapion, J. Spatz, A. Eggermont, A.M.M. Keilholz, U. Fusi, A. Suciu, S. Nonnenmacher, A. Santinami, M. Kruit, W.H.J. Testori, A. Punt, C.J.A. Dalgleish, A.G. |
2013-04-29
|
|
The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases
(Article)
Zdzienicki, M. Rutkowski, P. Eggermont, A.M.M. Nowecki, Z.I. Akkooi, A.C.J. van Michej, W. Dziewirski, W. Świtaj, T. Pieńkowski, A. Sałamacha, M. Bylina, E. |
2013-03-01
|
|
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells
(Article)
Horssen, R. van Hollestelle, A. Rens, J.A.P. Eggermont, A.M.M. Schutte, A.E.M. Hagen, T.L.M.T. |
2012-11-01
|
|
Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection
(Article)
Ploeg, A.P.T. van der Akkooi, A.C.J. van Rutkowski, P. Cook, M. Nieweg, O.E. Rossi, C.R. Testori, A. Suciu, S. Verhoef, C. Eggermont, A.M.M. |
2012-10-01
|
|
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: A population-based series
(Article)
Pool, A.E.M. van der Damhuis, R.A. IJzermans, J.N.M. Wilt, J.H.W. de Eggermont, A.M.M. Kranse, R. Verhoef, C. |
2012-01-01
|
|
Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
(Article)
Deroose, J.P. Grünhagen, D.J. Geel, A.N. van Wilt, J.H.W. de Eggermont, A.M.M. Verhoef, C. |
2011-11-01
|
|
Angiogenesis: A prognostic determinant in pancreatic cancer?
(Article)
Zee, J. van der Eijck, C.H.J. van Hop, W.C.J. Dekken, H. van Dicheva, B.M. Seynhaeve, A.L.B. Koning, G.A. Eggermont, A.M.M. Hagen, T.L.M. ten |
2011-11-01
|
|
Long-term results of tumor necrosis factor α- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas
(Article)
Deroose, J.P. Eggermont, A.M.M. Geel, A.N. van Burger, J.W.A. Bakker, M.A. den Wilt, J.H.W. de Verhoef, C. |
2011-10-20
|
|
Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
(Article)
Ayez, N. Lalmahomed, Z.S. Eggermont, A.M.M. IJzermans, J.N.M. Jonge, J. de Montfort, C.A.G.M. van Verhoef, C. |
2011-10-17
|
|
Multimodality approach to the sentinel node: An algorithm for the use of presentinel lymph node biopsy ultrasound (after lymphoscintigraphy) in conjunction with presentinel lymph node biopsy fine needle aspiration cytology
(Article)
Voit, C. Akkooi, A.C.J. van Schäfer-Hesterberg, G. Sterry, W. Eggermont, A.M.M. |
2011-10-01
|
